Related Experiment Videos
Effective population management practices in diabetes care - an observational study
Anne Frølich1, Jim Bellows, Bo Friis Nielsen
1Department of Integrated Healthcare, Bispebjerg Hospital, Copenhagen, Denmark. anne.frolich@dadlnet.dk
BMC Health Services Research
|September 23, 2010
Summary
Provider alerts significantly improve glycemic and lipid monitoring in diabetes care. Other practices like action plans show weaker associations, indicating alerts are key for better patient outcomes.
Area of Science:
- Diabetes Management
- Evidence-Based Medicine
- Healthcare Quality Improvement
Background:
- Delivering evidence-based medicine to diabetes patients is challenging.
- The chronic care model uses management practices to support evidence-based care.
- Effectiveness of simultaneous diabetes care practices remains unclear.
Purpose of the Study:
- Evaluate the impact of 15 concurrent diabetes care management practices.
- Assess how varying implementation levels affect glycemic and lipid monitoring.
Main Methods:
- Assessed implementation of 15 practices in 41 medical centers (553,556 adults).
- Used structured interviews with key informants to gauge practice levels.
- Employed stepwise logistic regression to link practices to monitoring outcomes.
Main Results:
- Provider alerts strongly correlated with higher glycemic (OR=4.07) and lipid (OR=1.63) monitoring.
- Action plans showed weaker association with glycemic monitoring (OR=1.44).
- Guideline distribution/training weakly linked to lipid monitoring (OR=1.46).
Conclusions:
- Provider alerts are most associated with high performance in diabetes care monitoring.
- Action plans and guideline distribution/training show weaker associations.
- Effective practices may be context-dependent or too complex for observational studies.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...